Addictions Management
Articles & Whitepapers
-
Combatting the Opioid Crisis with Cell Therapies for Chronic Back Pain
It’s no secret that opioid addiction is at an all-time high and represents a major public health threat. The CDC estimates that opioid addiction resulted in a record 72,000 drug overdose deaths in 2017 alone. What strikes me as one of the most tragic parts of this narrative is that so many of these deaths were people who became addicted to opioids after simply seeking relief ...
-
Carfentanil Exposure: Everything to Know About the Elephant Tranquilizer Drug
The synthetic opioid crisis has catapulted in recent years with the expansion of opioids and their effects on human health significantly magnified. Synthetic opioids are man-made drugs that replicate ...
News
-
Neuropathix, Inc. Highlights Revenue Related to its Grant Award with NIH-NINDS
The three-year $2.97 million Phase 2 STTR Study Grant through the NIH HEAL Initiative (Helping End Addiction Long-term) is providing funding specifically in the Development of KLS-13019 for Neuropathic Pain DOYLESTOWN, PA – May 25, 2022 ...
Pain management: at the core of canada`s opioid crisis
Neuropathix, Inc. Highlights Positive Preclinical Study Results on Lead Drug Candidate KLS-13019
Neuropathix, Inc. CEO Issues New Letter to Shareholders; Updates Market on Milestones in Research and Funding
Neuropathix, Inc. Receives Patent Grant from India for its Novel Anti-Inflammatory Compounds
Equipment & Solutions
-
Showcase
Medical Cannabis
CQ1 (Mentabinol) – As per CanaQuest’s September 17, 2019, press release, this game-changing discovery, Mentabinol, protects consumers from acute & long-term negative psychiatric side effects of THC intake. This formulation utilizing Food-Grade Botanical Extract “BX” and extracted THC oil from the marijuana “MJ” plant addresses four major problems resulting ...